Dr. Ben Locwin
Black Diamond Networks
Executive
COVID-19: Architecture of a Pandemic

David H. Windley, CFA, CPA
Jefferies LLC
Managing Director
Contract Manufacturing Opportunity: COVID Catalyst for Supply Chain Conversion

Dr. Mark Saunders
P2C-Pharma Ltd.
Consultant
Keys to Success in Accelerating Early to Mid-Phase Drug Development

Eric S. Langer, MSB
BioPlan Associates, Inc.
President and Managing Partner
Impact of Covid-19 on Bioprocessing Facilities and Suppliers

John Avellanet
Cerulean Associates
Managing Director & Principal
Data Integrity Trends in Remote Inspection Findings

Michael Tousey
Techceuticals
CEO and Technical Director
Oral Solid Dose Quality and Production

Peter F. Sturtevant
GS1 US
Senior Director of Community Engagement
Achieve DSCSA Serialized Interoperability Required by 2023

Ricki A. Chase, M.S.
Lachman Consultant Services, Inc.
Executive Director
FDA Regulations and Inspections Amid COVID-19

Stephen Sayre
Dykema
Member
Understanding Your CDMO: A Legal Perspective on Quality Agreements

Susan Fyan
Perrigo Company
Senior Legal Counsel
Understanding Your CDMO: A Legal Perspective on Quality Agreements

Vanessa Brill
Dr. Reddy’s Laboratories operations in the Americas
Vice President and Regional General Counsel
Maintaining Critical Drug Supply During the Pandemic

Vincent Colicchio
Dr. Reddy’s Laboratories
Vice President, Supply Chain and External Manufacturing
Maintaining Critical Drug Supply During the Pandemic